CME Group Future Growth

Future criteria checks 1/6

CME Group is forecast to grow earnings and revenue by 3.4% and 4.3% per annum respectively. EPS is expected to grow by 3.5% per annum. Return on equity is forecast to be 13.3% in 3 years.

Key information

3.4%

Earnings growth rate

3.5%

EPS growth rate

Capital Markets earnings growth	15.6%
Revenue growth rate	4.3%
Future return on equity	13.3%
Analyst coverage	Good
Last updated	19 Apr 2024

Recent future growth updates

No updates

Recent updates

CME Group: Appealing Business Characteristics That Could Benefit From Geopolitical Uncertainty

Apr 15

We Think Some Shareholders May Hesitate To Increase CME Group Inc.'s (NASDAQ:CME) CEO Compensation

Apr 28

CME Group (NASDAQ:CME) Is Paying Out A Larger Dividend Than Last Year

Dec 15

CME Group ADV climbs 21% Y/Y to 6.1M in Q3

Oct 11

CME Group Is The Perfect Dividend Stock To Buy While It's Cheap

Sep 30

CME Group launches ethereum options ahead of this week's blockchain Merge

Sep 12

With EPS Growth And More, CME Group (NASDAQ:CME) Makes An Interesting Case

Sep 08

CME Group proposes converting eurodollar futures, options contracts to SOFR

Sep 06

CME Group launches bitcoin Euro and ether Euro futures

Aug 29

CME Group set to launch ether futures options in September

Aug 18

CME Group ADV perks up 20% in July in wake of volatile markets

Aug 02

CME Q2 2022 Earnings Preview

Jul 26

CME achieves 21% growth in Q2 international ADV

Jul 12

CME Group average daily volume jumps to 24M contracts in June

Jul 05

CME Nears A Do-Or-Die Moment

May 27

Why CME Should Be In Our Dividend Growth Portfolios

Apr 30

Is Now The Time To Put CME Group (NASDAQ:CME) On Your Watchlist?

Apr 15

Earnings and Revenue Growth Forecasts

NasdaqGS:CME - Analysts future estimates and past financials data (USD Millions)
Date	Revenue	Earnings	Free Cash Flow	Cash from Op	Avg. No. Analysts
12/31/2026	6,431	3,607	3,951	4,037	8
12/31/2025	6,082	3,443	3,746	3,897	14
12/31/2024	5,839	3,326	3,670	3,781	14
12/31/2023	5,569	3,186	3,377	3,454	N/A
9/30/2023	5,338	3,011	3,311	3,391	N/A
6/30/2023	5,228	2,942	3,108	3,192	N/A
3/31/2023	5,104	2,828	3,078	3,159	N/A
12/31/2022	5,009	2,657	2,966	3,056	N/A
9/30/2022	4,833	2,633	2,650	2,743	N/A
6/30/2022	4,715	2,889	2,616	2,717	N/A
3/31/2022	4,657	2,745	2,477	2,599	N/A
12/31/2021	4,690	2,617	2,275	2,402	N/A
9/30/2021	4,630	2,435	2,225	2,394	N/A
6/30/2021	4,600	1,920	1,888	2,074	N/A
3/31/2021	4,603	1,913	2,378	2,561	N/A
12/31/2020	4,884	2,105	2,518	2,716	N/A
9/30/2020	4,911	2,151	2,581	2,775	N/A
6/30/2020	5,109	2,375	3,071	3,274	N/A
3/31/2020	5,200	2,386	2,521	2,761	N/A
12/31/2019	4,868	2,117	2,427	2,673	N/A
9/30/2019	4,959	2,033	2,229	2,464	N/A
6/30/2019	4,588	1,808	2,027	2,236	N/A
3/31/2019	4,377	1,860	2,137	2,285	N/A
12/31/2018	4,309	1,962	2,324	2,441	N/A
9/30/2018	3,973	4,516	2,301	2,391	N/A
6/30/2018	3,959	4,413	2,242	2,316	N/A
3/31/2018	3,824	4,262	1,977	2,057	N/A
12/31/2017	3,645	4,063	1,669	1,751	N/A
9/30/2017	3,658	1,498	N/A	1,801	N/A
6/30/2017	3,609	1,662	N/A	1,773	N/A
3/31/2017	3,590	1,566	N/A	1,732	N/A
12/31/2016	3,595	1,534	N/A	1,732	N/A
9/30/2016	3,496	1,452	N/A	1,607	N/A
6/30/2016	3,505	1,340	N/A	1,591	N/A
3/31/2016	3,418	1,284	N/A	1,626	N/A
12/31/2015	3,327	1,247	N/A	1,533	N/A
9/30/2015	3,354	1,262	N/A	1,644	N/A
6/30/2015	3,266	1,192	N/A	1,414	N/A
3/31/2015	3,178	1,191	N/A	1,327	N/A
12/31/2014	3,113	1,127	N/A	1,291	N/A
9/30/2014	2,958	1,014	N/A	1,171	N/A
6/30/2014	2,911	960	N/A	1,066	N/A
3/31/2014	2,990	1,008	N/A	1,268	N/A
12/31/2013	2,931	977	N/A	1,281	N/A
9/30/2013	2,905	951	N/A	1,221	N/A
6/30/2013	2,874	932	N/A	1,331	N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: CME's forecast earnings growth (3.4% per year) is above the savings rate (2.3%).

Earnings vs Market: CME's earnings (3.4% per year) are forecast to grow slower than the US market (14.5% per year).

High Growth Earnings: CME's earnings are forecast to grow, but not significantly.

Revenue vs Market: CME's revenue (4.3% per year) is forecast to grow slower than the US market (8.1% per year).

High Growth Revenue: CME's revenue (4.3% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: CME's Return on Equity is forecast to be low in 3 years time (13.3%).

Discover growth companies

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

CME Group Future Growth

Future criteria checks 1/6

Key information

Recent future growth updates

Recent updates

CME Group: Appealing Business Characteristics That Could Benefit From Geopolitical Uncertainty

CME Group: Improved Valuation Offset By Low Market Volatility And Higher Rates

CME Group Inc. to Report Q1, 2024 Results on Apr 24, 2024

CME Group (NASDAQ:CME) Will Pay A Dividend Of $1.15

Now 20% overvalued after recent price rise

Full year 2023 earnings: EPS exceeds analyst expectations

CME Group Is One Of My Favorite High-Yielding Stocks Today

Upcoming dividend of US$1.15 per share

CME Group to Launch Micro Euro-Denominated Bitcoin and Ether Futures on March 18

CME Group (NASDAQ:CME) Has Announced A Dividend Of $1.15

CME Group Launches Clearing Service for Mexican F-TIIE Overnight Index Swaps

Full year 2023 earnings: EPS exceeds analyst expectations

CME Group: Buying 'The House' Proves A Winning Strategy

Now 23% overvalued after recent price rise

Dividend increased to US$1.15

CME Group Declares Quarterly Dividend, Payable on March 26, 2024

CME Group: Uncertainty In The World Equals Higher Revenue Growth

CME Group to Launch E-mini S&P 500 Equal Weight Futures on February 26

Saudi Tadawul Group Holding Company (SASE:1111) entered into a binding agreement to acquire unknown minority stake in Dubai Mercantile Exchange Limited from a group of sellers.

CME Group to Launch Longer-Dated Event Contracts on January 29

Getting In Cheap On CME Group Inc. (NASDAQ:CME) Is Unlikely

CME Group Inc. to Report Q4, 2023 Results on Feb 14, 2024

Upcoming dividend of US$5.25 per share at 4.5% yield

CME Group Inc., Annual General Meeting, May 09, 2024

CME Group Declares Annual Variable Dividend, Payable on January 18, 2024

Insider recently sold US$2.8m worth of stock

CME Group to Launch FX Spot+ to Connect Otc and Futures Liquidity

Upcoming dividend of US$1.10 per share at 4.1% yield

Here's Why CME Group (NASDAQ:CME) Has Caught The Eye Of Investors

CME Group Inc. Declares a Fourth-Quarter Dividend, Payable on December 28, 2023

CME Group Expands Suite of Short-Term Options on U.S. Treasury Futures

Third quarter 2023 earnings: EPS misses analyst expectations

CME Group Inc. to Report Q3, 2023 Results on Oct 25, 2023

CME Group to Launch T-Bill Futures on October 2, as U.S. Treasury Futures Open Interest Hits Record 19.8 Million Contracts

Upcoming dividend of US$1.10 per share at 4.4% yield

Chairman & CEO notifies of intention to sell stock

Insider recently sold US$1.3m worth of stock

Chief Information Officer notifies of intention to sell stock

CME Group Inc. Declares Third-Quarter Dividend, Payable on September 27, 2023

New minor risk - Insider selling

Chief Information Officer recently sold US$2.0m worth of stock

Second quarter 2023 earnings: EPS in line with analyst expectations despite revenue beat

CME Group Inc. to Report Q2, 2023 Results on Jul 26, 2023

Upcoming dividend of US$1.10 per share at 5.0% yield

CME Group Inc. Elects Harold Ford and Duffy, Kathryn Benesh as Directors

Cme Group Inc. Declares Quarterly Dividend, Payable on June 27, 2023

We Think Some Shareholders May Hesitate To Increase CME Group Inc.'s (NASDAQ:CME) CEO Compensation

First quarter 2023 earnings: EPS and revenues exceed analyst expectations

Independent Director recently bought US$94k worth of stock

Upcoming dividend of US$1.10 per share at 4.8% yield

Full year 2022 earnings: Revenues and EPS in line with analyst expectations

CME Group Inc. Announces Director Retirements

Independent Director recently bought US$279k worth of stock

CME Group to Launch Micro E-Mini Nasdaq-100 and S&P 500 Monday, Tuesday, Wednesday and Thursday Weekly Options on February 13

CME Group Inc. to Report Q4, 2022 Results on Feb 08, 2023

Upcoming dividend of US$4.50 per share

CME Group (NASDAQ:CME) Is Paying Out A Larger Dividend Than Last Year

CME Group Inc., Annual General Meeting, May 04, 2023

CME Group Inc Declares Annual Variable Dividend, Payable on January 18, 2023

Insider recently bought US$265k worth of stock

Upcoming dividend of US$1.00 per share

CME Group Inc. Declares Fourth-Quarter Dividend, Payable December 28, 2022

Independent Director recently bought US$8.3m worth of stock

Third quarter 2022 earnings: EPS exceeds analyst expectations

CME Group Inc. Appoints Jonathan Marcus as General Counsel

CME Group ADV climbs 21% Y/Y to 6.1M in Q3

CME Group and CF Benchmarks to Launch Three New Cryptocurrency Reference Rates and Real-Time Indices on October 31, 2022

CME Group Inc. Announces Board Appointments

CME Group Is The Perfect Dividend Stock To Buy While It's Cheap

CME Group Inc. to Report Q3, 2022 Results on Oct 26, 2022

Insider recently sold US$806k worth of stock

CME Group launches ethereum options ahead of this week's blockchain Merge

With EPS Growth And More, CME Group (NASDAQ:CME) Makes An Interesting Case

CME Group proposes converting eurodollar futures, options contracts to SOFR

Upcoming dividend of US$1.00 per share